Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P. Laurent, Sébastien Malinge, Aurélie Siret et al.|Clinical Cancer Research|2020Cited by 23
Figure S7 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P. Laurent, Sébastien Malinge, Aurélie Siret et al.|Unknown|2023Cited by 0
Supplementary Data from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P. Laurent, Sébastien Malinge, Aurélie Siret et al.|Unknown|2023Cited by 0
Supplementary Table 3 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P. Laurent, Sébastien Malinge, Aurélie Siret et al.|Unknown|2023Cited by 0
Supplementary Table 2 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P. Laurent, Sébastien Malinge, Aurélie Siret et al.|Unknown|2023Cited by 0